Identification Generic Name (1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE DrugBank Accession Number DB08176 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 Download  MOL SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE (DB08176) ×  Close Weight Average: 177.2181  Monoisotopic: 177.095377594  Chemical Formula C 11 H 12 FN Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Amine oxidase [flavin-containing] B Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Classification Not classified Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key CFVUPEQWSFCCFT-MDWZMJQESA-N InChI InChI=1S/C11H12FN/c1-9(8-13)2-3-10-4-6-11(12)7-5-10/h4-8,13H,1-3H2/b13-8+ IUPAC Name 1-(3-carboximidoylbut-3-en-1-yl)-4-fluorobenzene SMILES [H]N=C([H])C(=C)CCC1=CC=C(F)C=C1 References General References Not Available External Links PubChem Compound 46937129 PubChem Substance 99444647 ChemSpider 25057653 PDBe Ligand MFG PDB Entries 2vz2 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0226 mg/mL ALOGPS logP 2.49 ALOGPS logP 2.95 Chemaxon logS -3.9 ALOGPS pKa (Strongest Basic) 10.02 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 1 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 23.85 Å 2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 62.71 m 3 ·mol -1 Chemaxon Polarizability 18.77 Å 3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9331 Blood Brain Barrier + 0.953 Caco-2 permeable + 0.6383 P-glycoprotein substrate Non-substrate 0.6745 P-glycoprotein inhibitor I Non-inhibitor 0.6911 P-glycoprotein inhibitor II Non-inhibitor 0.8492 Renal organic cation transporter Non-inhibitor 0.563 CYP450 2C9 substrate Non-substrate 0.8677 CYP450 2D6 substrate Non-substrate 0.7621 CYP450 3A4 substrate Non-substrate 0.6555 CYP450 1A2 substrate Inhibitor 0.5842 CYP450 2C9 inhibitor Non-inhibitor 0.7595 CYP450 2D6 inhibitor Non-inhibitor 0.6677 CYP450 2C19 inhibitor Non-inhibitor 0.6097 CYP450 3A4 inhibitor Inhibitor 0.5819 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.6716 Ames test Non AMES toxic 0.5273 Carcinogenicity Non-carcinogens 0.7099 Biodegradation Not ready biodegradable 0.9496 Rat acute toxicity 2.4191 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.7444 hERG inhibition (predictor II) Non-inhibitor 0.8635    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Amine oxidase [flavin-containing] B Kind Protein Organism Humans Pharmacological action Unknown General Function Primary amine oxidase activity Specific Function Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral... Gene Name MAOB Uniprot ID P27338 Uniprot Name Amine oxidase [flavin-containing] B Molecular Weight 58762.475 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:29 / Updated at June 12, 2020 16:52 